Karuna Therapeutics, INC.

Clinical-stage biopharmaceutical company

Based in MA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $200K in lobbying spend across 5 quarterly filings, Karuna Therapeutics, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2023 to 2024.

$200K
Total Spend
2
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$100K
2024$100K

Issues Lobbied

Health Issues

Lobbying Firms

Avenue Solutions

Lobbyists

Elizabeth BarnettTracy Spicer

Government Agencies Targeted

These are the government entities that Karuna Therapeutics, INC. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Education around innovation in schizophrenia

Education around innovation in schizophrenia; Issues related to mental health; Expiring healthcare extenders

Education around innovation in schizophrenia; Issues related to mental health; Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Akebia Therapeutics, INC.
$9.8M total spend
Ardelyx, INC.
$9.4M total spend
Sumitomo Pharma America, INC. (Formerly Sunovion Pharmaceuticals INC.)
$7.5M total spend
Sage Therapeutics
$4.8M total spend
Organogenesis INC.
$4.0M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.